Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Nature ; 2023 Jul 19.
Article in English | MEDLINE | ID: mdl-37468814
2.
Ann Neurol ; 90(4): 558-567, 2021 10.
Article in English | MEDLINE | ID: mdl-34402546

ABSTRACT

Central nervous system demyelination in multiple sclerosis (MS) and subsequent axonal degeneration represent a major cause of clinical morbidity. Learning, salient experiences, and stimulation of neuronal activity induce new myelin formation in rodents, and in animal models of demyelination, remyelination can be enhanced via experience- and activity-dependent mechanisms. Furthermore, preliminary studies in MS patients support the use of neuromodulation and rehabilitation exercises for symptomatic improvement, suggesting that these interventions may represent nonpharmacological strategies for promoting remyelination. Here, we review the literature on myelin plasticity processes and assess the potential to leverage these mechanisms to develop remyelinating therapies. ANN NEUROL 2021;90:558-567.


Subject(s)
Multiple Sclerosis/drug therapy , Myelin Sheath/metabolism , Neuronal Plasticity/physiology , Remyelination/physiology , Animals , Humans , Myelin Sheath/drug effects , Neurons/cytology , Oligodendroglia/cytology , Remyelination/drug effects
3.
J Vasc Interv Radiol ; 32(4): 527-535.e1, 2021 04.
Article in English | MEDLINE | ID: mdl-33518369

ABSTRACT

PURPOSE: To evaluate the efficacy and safety of percutaneous ablation of adrenal metastases through a meta-analysis of various image-guided percutaneous ablation techniques. MATERIALS AND METHODS: A comprehensive literature search of PubMed and Embase databases was performed for studies evaluating the efficacy and/or safety of image-guided percutaneous ablation of adrenal metastases. A total of 37 studies published between 2009 and 2020 were analyzed, comprising a sample size of 959 patients. Proportion estimates of overall survival, local control, and toxicity were analyzed in a pooled meta-analysis. The pooled prevalence of adverse events after ablation was calculated based on common terminology criteria for adverse events (CTCAE) grading. RESULTS: Of the 959 included patients, 320 (33.3%) underwent radiofrequency ablation, 72 (7.5%) microwave ablation, 95 (9.9%) cryoablation, and 46 (4.8%) ethanol injections for treatment of adrenal metastases. The remaining 426 (44.4%) patients were from studies involving a mixture of the 4 listed percutaneous ablation techniques. The pooled 1-year local control rate was 80% (95% confidence interval [CI], 76%-83%). The pooled 1-year overall survival rate was 77% (95% CI, 70%-83%). The overall rate of severe adverse events after ablation (CTCAE grade 3 or higher) was 16.1%. The overall rate of low-grade adverse events after ablation (CTCAE grade 2 or lower) was 32.6%. Approximately 21.9% (n = 203) of patients experienced intraprocedural hypertensive crises, the majority of which were reversed with antihypertensive medications. CONCLUSIONS: This study demonstrates that image-guided percutaneous ablation can be effective in achieving acceptable short- to mid-term local tumor control and overall survival with a moderate safety profile.


Subject(s)
Ablation Techniques , Adrenal Gland Neoplasms/secondary , Adrenal Gland Neoplasms/surgery , Surgery, Computer-Assisted , Ablation Techniques/adverse effects , Ablation Techniques/mortality , Adrenal Gland Neoplasms/diagnostic imaging , Adrenal Gland Neoplasms/mortality , Aged , Female , Humans , Male , Middle Aged , Postoperative Complications/mortality , Prevalence , Risk Assessment , Risk Factors , Surgery, Computer-Assisted/adverse effects , Surgery, Computer-Assisted/mortality , Time Factors , Treatment Outcome
4.
Acad Radiol ; 27(11): 1507-1514, 2020 11.
Article in English | MEDLINE | ID: mdl-32912668

ABSTRACT

RATIONALE AND OBJECTIVES: An increasing number of neurological complications and corresponding radiological findings have been reported in patients with COVID-19 infection. The purpose of this study is to systematically review the current literature on COVID-19-associated neuroradiological findings and examine the prevalence of different findings in patients with both severe and mild COVID-19 infection. MATERIALS AND METHODS: A comprehensive literature search of the PubMed and Embase databases was performed. Any studies reporting CT or MRI neuroimaging findings in patients with confirmed COVID-19 infection were included. Patient demographics, main radiological findings, neurological symptoms, and severity of COVID-19 infection were tabulated and quantified according to infection severity. RESULTS: Sixty-one studies published between 2019 and 2020 comprising 711 patients were analyzed according to severity of respiratory symptoms. The main neuroradiological findings for patients with mild classification were cranial nerve abnormalities, ischemic infarction, and white matter abnormalities, while the main findings in patients with severe classification were white matter abnormalities, ischemic infarction, and hemorrhagic events. CONCLUSION: Neuroradiological manifestations in COVID-19 infection are highly heterogeneous and differ based on the severity of COVID-19 infection. Cranial nerve abnormalities appear exclusive to mild infection, with a high degree of olfactory tract involvement, while hemorrhagic events are more common in severe infection. Notably, ischemic infarction was equally prevalent in both mild and severe COVID-19 infection. Healthcare providers treating COVID-19 patients should be aware of these potential complications and consider neurological assessment and neuroimaging studies when indicated.


Subject(s)
Betacoronavirus , Coronavirus Infections , Nervous System Diseases , Pandemics , Pneumonia, Viral , COVID-19 , Coronavirus Infections/complications , Humans , Nervous System Diseases/virology , Pneumonia, Viral/epidemiology , SARS-CoV-2
5.
Cell ; 182(2): 388-403.e15, 2020 07 23.
Article in English | MEDLINE | ID: mdl-32615087

ABSTRACT

Synapse remodeling is essential to encode experiences into neuronal circuits. Here, we define a molecular interaction between neurons and microglia that drives experience-dependent synapse remodeling in the hippocampus. We find that the cytokine interleukin-33 (IL-33) is expressed by adult hippocampal neurons in an experience-dependent manner and defines a neuronal subset primed for synaptic plasticity. Loss of neuronal IL-33 or the microglial IL-33 receptor leads to impaired spine plasticity, reduced newborn neuron integration, and diminished precision of remote fear memories. Memory precision and neuronal IL-33 are decreased in aged mice, and IL-33 gain of function mitigates age-related decreases in spine plasticity. We find that neuronal IL-33 instructs microglial engulfment of the extracellular matrix (ECM) and that its loss leads to impaired ECM engulfment and a concomitant accumulation of ECM proteins in contact with synapses. These data define a cellular mechanism through which microglia regulate experience-dependent synapse remodeling and promote memory consolidation.


Subject(s)
Extracellular Matrix/metabolism , Microglia/physiology , Neuronal Plasticity/physiology , Aging , Animals , Fear , Gene Expression Regulation , Hippocampus/metabolism , Interleukin-1 Receptor-Like 1 Protein/genetics , Interleukin-1 Receptor-Like 1 Protein/metabolism , Interleukin-33/genetics , Interleukin-33/metabolism , Memory , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neurons/metabolism , Signal Transduction
6.
Nat Neurosci ; 23(4): 487-499, 2020 04.
Article in English | MEDLINE | ID: mdl-32042175

ABSTRACT

Experience-dependent myelination is hypothesized to shape neural circuit function and subsequent behavioral output. Using a contextual fear memory task in mice, we demonstrate that fear learning induces oligodendrocyte precursor cells to proliferate and differentiate into myelinating oligodendrocytes in the medial prefrontal cortex. Transgenic animals that cannot form new myelin exhibit deficient remote, but not recent, fear memory recall. Recording population calcium dynamics by fiber photometry, we observe that the neuronal response to conditioned context cues evolves over time in the medial prefrontal cortex, but not in animals that cannot form new myelin. Finally, we demonstrate that pharmacological induction of new myelin formation with clemastine fumarate improves remote memory recall and promotes fear generalization. Thus, bidirectional manipulation of myelin plasticity functionally affects behavior and neurophysiology, which suggests that neural activity during fear learning instructs the formation of new myelin, which in turn supports the consolidation and/or retrieval of remote fear memories.


Subject(s)
Cell Proliferation/physiology , Conditioning, Classical/physiology , Fear/physiology , Memory, Long-Term/physiology , Myelin Sheath/physiology , Oligodendrocyte Precursor Cells/physiology , Animals , Mice , Mice, Transgenic , Oligodendrocyte Transcription Factor 2/genetics , Prefrontal Cortex/physiology
7.
Cell Rep ; 27(7): 2171-2183.e5, 2019 05 14.
Article in English | MEDLINE | ID: mdl-31091454

ABSTRACT

Resilience of neural circuits has been observed in the persistence of function despite neuronal loss. In vision, acuity and sensitivity can be retained after 50% loss of cones. While neurons in the cortex can remodel after input loss, the contributions of cell-type-specific circuits to resilience are unknown. Here, we study the effects of partial cone loss in mature mouse retina where cell types and connections are known. At first-order synapses, bipolar cell dendrites remodel and synaptic proteins diminish at sites of input loss. Sites of remaining inputs preserve synaptic proteins. Second-order synapses between bipolar and ganglion cells remain stable. Functionally, ganglion cell spatio-temporal receptive fields retain center-surround structure following partial cone loss. We find evidence for slower temporal filters and expanded receptive field surrounds, derived mainly from inhibitory inputs. Surround expansion is absent in partially stimulated control retina. Results demonstrate functional resilience to input loss beyond pre-existing mechanisms in control retina.


Subject(s)
Retinal Cone Photoreceptor Cells/metabolism , Retinal Ganglion Cells/metabolism , Synapses/metabolism , Animals , Mice , Mice, Transgenic , Retinal Cone Photoreceptor Cells/pathology , Retinal Ganglion Cells/pathology , Synapses/pathology
8.
Elife ; 72018 11 07.
Article in English | MEDLINE | ID: mdl-30403373

ABSTRACT

Retinal dopamine is a critical modulator of high acuity, light-adapted vision and photoreceptor coupling in the retina. Dopaminergic amacrine cells (DACs) serve as the sole source of retinal dopamine, and dopamine release in the retina follows a circadian rhythm and is modulated by light exposure. However, the retinal circuits through which light influences the development and function of DACs are still unknown. Intrinsically photosensitive retinal ganglion cells (ipRGCs) have emerged as a prime target for influencing retinal dopamine levels because they costratify with DACs in the inner plexiform layer and signal to them in a retrograde manner. Surprisingly, using genetic mouse models lacking specific phototransduction pathways, we find that while light influences the total number of DACs and retinal dopamine levels, this effect does not require ipRGCs. Instead, we find that the rod pathway is a critical modulator of both DAC number and retinal dopamine levels.


Subject(s)
Amacrine Cells/cytology , Amacrine Cells/radiation effects , Dopamine/metabolism , Light , Amacrine Cells/metabolism , Animals , Cell Count , Female , Light Signal Transduction , Male , Mice , Models, Biological , Retinal Cone Photoreceptor Cells/metabolism , Retinal Cone Photoreceptor Cells/radiation effects , Retinal Ganglion Cells/metabolism , Retinal Ganglion Cells/radiation effects , Retinal Rod Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/radiation effects , Rod Opsins/metabolism , Tyrosine 3-Monooxygenase/metabolism
9.
Curr Biol ; 28(8): 1296-1305.e5, 2018 04 23.
Article in English | MEDLINE | ID: mdl-29628374

ABSTRACT

The correct targeting of myelin is essential for nervous system formation and function. Oligodendrocytes in the CNS myelinate some axons, but not others, and do not myelinate structures including cell bodies and dendrites [1]. Recent studies indicate that extrinsic signals, such as neuronal activity [2, 3] and cell adhesion molecules [4], can bias myelination toward some axons and away from cell bodies and dendrites, indicating that, in vivo, neuronal and axonal cues regulate myelin targeting. In vitro, however, oligodendrocytes have an intrinsic propensity to myelinate [5-7] and can promiscuously wrap inert synthetic structures resembling neuronal processes [8, 9] or cell bodies [4]. A current therapeutic goal for the treatment of demyelinating diseases is to greatly promote oligodendrogenesis [10-13]; thus, it is important to test how accurately extrinsic signals regulate the oligodendrocyte's intrinsic program of myelination in vivo. Here, we test the hypothesis that neurons regulate myelination with sufficient stringency to always ensure correct targeting. Surprisingly, however, we find that myelin targeting in vivo is not very stringent and that mistargeting occurs readily when oligodendrocyte and myelin supply exceed axonal demand. We find that myelin is mistargeted to neuronal cell bodies in zebrafish mutants with fewer axons and independently in drug-treated zebrafish with increased oligodendrogenesis. Additionally, by increasing myelin production of oligodendrocytes in zebrafish and mice, we find that excess myelin is also inappropriately targeted to cell bodies. Our results suggest that balancing oligodendrocyte-intrinsic programs of myelin supply with axonal demand is essential for correct myelin targeting in vivo and highlight potential liabilities of strongly promoting oligodendrogenesis.


Subject(s)
Cell Body/metabolism , Myelin Sheath/metabolism , Nerve Fibers, Myelinated/physiology , Animals , Animals, Genetically Modified , Axons/metabolism , Axons/physiology , Female , Male , Mice , Myelin Sheath/physiology , Nerve Fibers, Myelinated/metabolism , Neurons/physiology , Oligodendroglia/metabolism , Organogenesis/physiology , Zebrafish/metabolism , Zebrafish/physiology , Zebrafish Proteins/metabolism
10.
J Cell Biol ; 216(12): 3903-3916, 2017 12 04.
Article in English | MEDLINE | ID: mdl-29114067

ABSTRACT

Axon loss and neurodegeneration constitute clinically debilitating sequelae in demyelinating diseases such as multiple sclerosis, but the underlying mechanisms of secondary degeneration are not well understood. Myelinating glia play a fundamental role in promoting the maturation of the axon cytoskeleton, regulating axon trafficking parameters, and imposing architectural rearrangements such as the nodes of Ranvier and their associated molecular domains. In the setting of demyelination, these changes may be reversed or persist as maladaptive features, leading to axon degeneration. In this review, we consider recent insights into axon-glial interactions during development and disease to propose that disruption of the cytoskeleton, nodal architecture, and other components of axon infrastructure is a potential mediator of pathophysiological damage after demyelination.


Subject(s)
Axons/metabolism , Cytoskeleton/metabolism , Demyelinating Diseases/metabolism , Myelin Sheath/metabolism , Neurodegenerative Diseases/metabolism , Animals , Axons/pathology , Axons/ultrastructure , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Contactin 1/genetics , Contactin 1/metabolism , Cytoskeleton/pathology , Cytoskeleton/ultrastructure , Demyelinating Diseases/genetics , Demyelinating Diseases/pathology , Gene Expression Regulation , Humans , Ion Channels/genetics , Ion Channels/metabolism , Mice , Myelin Sheath/pathology , Myelin Sheath/ultrastructure , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology , Signal Transduction , Spectrin/genetics , Spectrin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...